159 related articles for article (PubMed ID: 23277333)
1. Expression of c-Src and phospho-Src in epithelial ovarian carcinoma.
Huang YW; Chen C; Xu MM; Li JD; Xiao J; Zhu XF
Mol Cell Biochem; 2013 Apr; 376(1-2):73-9. PubMed ID: 23277333
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of GRIM-19 in epithelial ovarian carcinoma].
Shao YP; Cheng XD; Wan XY
Zhonghua Fu Chan Ke Za Zhi; 2012 Oct; 47(10):751-5. PubMed ID: 23302733
[TBL] [Abstract][Full Text] [Related]
3. Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer.
Mei L; Hu Q; Peng J; Ruan J; Zou J; Huang Q; Liu S; Wang H
Int J Clin Exp Pathol; 2015; 8(5):5597-602. PubMed ID: 26191270
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between activated and inactivated c-Src in hepatocellular carcinoma.
Chen ML; Chai CY; Yeh KT; Wang SN; Tsai CJ; Yeh YT; Yang SF
Dis Markers; 2011; 30(6):325-33. PubMed ID: 21725161
[TBL] [Abstract][Full Text] [Related]
5. Ovarian sarcoma carries a poorer prognosis than ovarian epithelial cancer throughout all FIGO stages: a single-center case-control matched study.
Bacalbasa N; Balescu I; Dima S; Popescu I
Anticancer Res; 2014 Dec; 34(12):7303-8. PubMed ID: 25503164
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer.
Liu Z; Yun R; Yu X; Hu H; Huang G; Tan B; Chen T
Mediators Inflamm; 2016; 2016():5953498. PubMed ID: 27445438
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of cortactin protein in ovarian neoplasms.
Li A; Zhang L; Zhang X; Jin W; Ren Y
Clin Transl Oncol; 2016 Feb; 18(2):220-7. PubMed ID: 26243395
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
Zhao Y; Chen S; Gou WF; Xiao LJ; Takano Y; Zheng HC
Tumour Biol; 2014 Mar; 35(3):1955-64. PubMed ID: 24132590
[TBL] [Abstract][Full Text] [Related]
9. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.
Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y
Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963
[TBL] [Abstract][Full Text] [Related]
11. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M; He Y; Shi L; Shi C
Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
[TBL] [Abstract][Full Text] [Related]
13. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
Li T; Xue H; Guo Y; Guo K
Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of phospho-Src family kinase analysis in tongue cancer.
Ben-Izhak O; Cohen-Kaplan V; Nagler RM
J Cancer Res Clin Oncol; 2010 Jan; 136(1):27-34. PubMed ID: 19565264
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
Polterauer S; Vergote I; Concin N; Braicu I; Chekerov R; Mahner S; Woelber L; Cadron I; Van Gorp T; Zeillinger R; Castillo-Tong DC; Sehouli J
Int J Gynecol Cancer; 2012 Mar; 22(3):380-5. PubMed ID: 22266934
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
17. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
Leng R; Liao G; Wang H; Kuang J; Tang L
Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
[TBL] [Abstract][Full Text] [Related]
18. Expression of phosphorylated Akt and hTERT is associated with prognosis of epithelial ovarian carcinoma.
Lee YK; Chung HH; Kim JW; Song YS; Park NH
Int J Clin Exp Pathol; 2015; 8(11):14971-6. PubMed ID: 26823830
[TBL] [Abstract][Full Text] [Related]
19. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
20. High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma.
Ma Y; Ren Y; Zhang X; Lin L; Liu Y; Rong F; Wen W; Li F
Virchows Arch; 2014 Apr; 464(4):443-52. PubMed ID: 24458516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]